Updated: March 23, 2021 Premas Biotech and Oramed announce oral COVID-19 vaccine candidate that produces antibodies after a single dose Must Read Nationalindonesianupdates.com_admin - December 13, 2025Sumatra floods: evacuees drop to 654 thousand, BNPB reports Nationalindonesianupdates.com_admin - December 13, 2025W Sumatra governor urges land provision for temporary housing Nationalindonesianupdates.com_admin - December 13, 2025Govt ensures sufficient food, medicine stocks in disaster-hit regions Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. … Previous articleNeed GeNose in factories to revive economic activity: ministerNext articleState spending increased 1.2 percent as of February 2021: Mulyani Latest News National - December 13, 2025Sumatra floods: evacuees drop to 654 thousand, BNPB reportsThe National Disaster Mitigation Agency (BNPB) reported that the evacuees displaced by floods and landslides in Aceh, ... National W Sumatra governor urges land provision for temporary housing - December 13, 2025 National Govt ensures sufficient food, medicine stocks in disaster-hit regions - December 13, 2025 National Government begins temporary housing construction in West Sumatra - December 13, 2025 National Indonesia’s MPR sends 15,000 aid packages to disaster-hit Sumatra - December 13, 2025 More Articles Like This President Jokowi calls for a shift in defense policy BREAKING NEWS - October 5, 2021 Black & Veatch management consulting chosen to help drive SCG International’s electric vehicle transition in Thailand BREAKING NEWS - October 5, 2021 Australia successfully goes live With Everbridge Public Warning platform countrywide, representing official launch of the Australian Government’s next-generation national population alerting system BREAKING NEWS - October 5, 2021 PPKM outside Java-Bali extended till Oct 18 BREAKING NEWS - October 4, 2021
Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. …